Article Listing - Uptake of Peg-IFN agents for HCV in China and South Korea hindered by relatively high cost and their partial reimbursement status

16 March 1992

On group sales of $751.1 million for the year ended December 31, 1991 (reported in brief last week), Swiss-based Ares-Serono...

16 March 1992

Ahead of the company's 1991 financal results, which are due out next week, there has been a variety of comment...

16 March 1992

The US Bush Administration is strongly opposed to S 2060, the Senate legislation which proposes to end the market monopoly...

16 March 1992

The French general practitioners' union, MG-France, has warned of the effects which the health cost control deal just agreed between...

16 March 1992

After a long period of analysis and negotiation, Italy's LIFEGROUP, founded in 1991, has decided against proceeding with the planned...

16 March 1992

Excluding the pharmaceuical division which it sold to Yamanouchi last year, Dutch company Gist-Brocades saw turnover for 1991 increase by...

16 March 1992

- British Bio-technology Prod-ucts Ltd has expanded its range of in situ hybridization products to include a Detection Module for...

16 March 1992

- Imperial Chemical Indus-tries' Nolvadex (tamoxifen) is prolonging the lives of men with breast cancer, according to results of a...

16 March 1992

- Genzyme Corp, in collaboration with Robert Van Etten and colleagues at Purdue University, Indiana, has developed technol-ogy which could...

16 March 1992

- The combination of allopurinol and meglumine antimoniate is more effective than the latter alone for American cutaneous leishmaniasis, according...

Showing 94631-94640 of 95376 articles